404 related articles for article (PubMed ID: 28679652)
1. Long non-coding RNA expression profile in cytogenetically normal acute myeloid leukemia identifies a distinct signature and a new biomarker in NPM1-mutated patients.
De Clara E; Gourvest M; Ma H; Vergez F; Tosolini M; Dejean S; Demur C; Delabesse E; Recher C; Touriol C; Martelli MP; Falini B; Brousset P; Bousquet M
Haematologica; 2017 Oct; 102(10):1718-1726. PubMed ID: 28679652
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and biologic significance of long non-coding RNA profiling in younger adults with cytogenetically normal acute myeloid leukemia.
Papaioannou D; Nicolet D; Volinia S; Mrózek K; Yan P; Bundschuh R; Carroll AJ; Kohlschmidt J; Blum W; Powell BL; Uy GL; Kolitz JE; Wang ES; Eisfeld AK; Orwick SJ; Lucas DM; Caligiuri MA; Stone RM; Byrd JC; Garzon R; Bloomfield CD
Haematologica; 2017 Aug; 102(8):1391-1400. PubMed ID: 28473620
[TBL] [Abstract][Full Text] [Related]
3. INPP4B promotes cell survival via SGK3 activation in NPM1-mutated leukemia.
Jin H; Yang L; Wang L; Yang Z; Zhan Q; Tao Y; Zou Q; Tang Y; Xian J; Zhang S; Jing Y; Zhang L
J Exp Clin Cancer Res; 2018 Jan; 37(1):8. PubMed ID: 29343273
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutation.
Garciaz S; N'guyen Dasi L; Finetti P; Chevalier C; Vernerey J; Poplineau M; Platet N; Audebert S; Pophillat M; Camoin L; Bertucci F; Calmels B; Récher C; Birnbaum D; Chabannon C; Vey N; Duprez E
Clin Epigenetics; 2019 Oct; 11(1):141. PubMed ID: 31606046
[TBL] [Abstract][Full Text] [Related]
5. HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia.
Zhu G; Luo H; Feng Y; Guryanova OA; Xu J; Chen S; Lai Q; Sharma A; Xu B; Zhao Z; Feng R; Ni H; Claxton D; Guo Y; Mesa RA; Qiu Y; Yang FC; Li W; Nimer SD; Huang S; Xu M
Nat Commun; 2021 Mar; 12(1):1956. PubMed ID: 33782403
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD4 is correlated with an unfavorable prognosis in wild-type NPM1, FLT3-ITD-negative cytogenetically normal adult acute myeloid leukemia.
Guo RJ; Atenafu EG; Schimmer AD; Minden MD; Chang H
Int J Lab Hematol; 2017 Aug; 39(4):429-437. PubMed ID: 28318150
[TBL] [Abstract][Full Text] [Related]
7. miRNA-mRNA Profiling Reveals Prognostic Impact of
Gadewal N; Kumar R; Aher S; Gardane A; Gaur T; Varma AK; Khattry N; Hasan SK
Oncol Res; 2020 May; 28(3):321-330. PubMed ID: 32059753
[TBL] [Abstract][Full Text] [Related]
8. The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature.
Díaz-Beyá M; Brunet S; Nomdedéu J; Pratcorona M; Cordeiro A; Gallardo D; Escoda L; Tormo M; Heras I; Ribera JM; Duarte R; de Llano MP; Bargay J; Sampol A; Nomdedeu M; Risueño RM; Hoyos M; Sierra J; Monzo M; Navarro A; Esteve J;
Oncotarget; 2015 Oct; 6(31):31613-27. PubMed ID: 26436590
[TBL] [Abstract][Full Text] [Related]
9. NPM1 alternative transcripts are upregulated in acute myeloid and lymphoblastic leukemia and their expression level affects patient outcome.
Handschuh L; Wojciechowski P; Kazmierczak M; Marcinkowska-Swojak M; Luczak M; Lewandowski K; Komarnicki M; Blazewicz J; Figlerowicz M; Kozlowski P
J Transl Med; 2018 Aug; 16(1):232. PubMed ID: 30126426
[TBL] [Abstract][Full Text] [Related]
10. Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients.
Dufour A; Schneider F; Hoster E; Benthaus T; Ksienzyk B; Schneider S; Kakadia PM; Sauerland MC; Berdel WE; Büchner T; Wörmann B; Braess J; Subklewe M; Hiddemann W; Bohlander SK; Spiekermann K;
Ann Hematol; 2012 Jul; 91(7):1051-63. PubMed ID: 22362118
[TBL] [Abstract][Full Text] [Related]
11. AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features.
Haferlach C; Mecucci C; Schnittger S; Kohlmann A; Mancini M; Cuneo A; Testoni N; Rege-Cambrin G; Santucci A; Vignetti M; Fazi P; Martelli MP; Haferlach T; Falini B
Blood; 2009 Oct; 114(14):3024-32. PubMed ID: 19429869
[TBL] [Abstract][Full Text] [Related]
12. Two Novel Mutations of the NPM1 Gene in Syrian Adult Patients with Acute Myeloid Leukemia and Normal Karyotype.
Alarbeed IF; Wafa A; Moassass F; Al-Halabi B; Alachkar W; Aboukhamis I
Asian Pac J Cancer Prev; 2021 Jan; 22(1):227-232. PubMed ID: 33507703
[TBL] [Abstract][Full Text] [Related]
13.
Kumar D; Mehta A; Panigrahi MK; Nath S; Saikia KK
Turk J Haematol; 2018 Mar; 35(1):49-53. PubMed ID: 29129825
[TBL] [Abstract][Full Text] [Related]
14. Expression and prognostic impact of lncRNAs in acute myeloid leukemia.
Garzon R; Volinia S; Papaioannou D; Nicolet D; Kohlschmidt J; Yan PS; Mrózek K; Bucci D; Carroll AJ; Baer MR; Wetzler M; Carter TH; Powell BL; Kolitz JE; Moore JO; Eisfeld AK; Blachly JS; Blum W; Caligiuri MA; Stone RM; Marcucci G; Croce CM; Byrd JC; Bloomfield CD
Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18679-84. PubMed ID: 25512507
[TBL] [Abstract][Full Text] [Related]
15. Impact of additional genetic alterations on the outcome of patients with NPM1-mutated cytogenetically normal acute myeloid leukemia.
Peterlin P; Renneville A; Ben Abdelali R; Nibourel O; Thomas X; Pautas C; de Botton S; Raffoux E; Cayuela JM; Boissel N; Terré C; Celli-Lebras K; Castaigne S; Preudhomme C; Gardin C; Dombret H
Haematologica; 2015 May; 100(5):e196-9. PubMed ID: 25552703
[No Abstract] [Full Text] [Related]
16. A novel leukemic route of mutant NPM1 through nuclear import of the overexpressed long noncoding RNA LONA.
Gourvest M; De Clara E; Wu HC; Touriol C; Meggetto F; De Thé H; Pyronnet S; Brousset P; Bousquet M
Leukemia; 2021 Oct; 35(10):2784-2798. PubMed ID: 34131282
[TBL] [Abstract][Full Text] [Related]
17. Mutated NPM1 in patients with acute myeloid leukemia in remission and relapse.
Jain P; Kantarjian H; Patel K; Faderl S; Garcia-Manero G; Benjamini O; Borthakur G; Pemmaraju N; Kadia T; Daver N; Nazha A; Luthra R; Pierce S; Cortes J; Ravandi F
Leuk Lymphoma; 2014 Jun; 55(6):1337-44. PubMed ID: 24004182
[TBL] [Abstract][Full Text] [Related]
18. Minimal/Measurable Residual Disease Monitoring in
Forghieri F; Comoli P; Marasca R; Potenza L; Luppi M
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30404199
[TBL] [Abstract][Full Text] [Related]
19. Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemia.
Walker CJ; Mrózek K; Ozer HG; Nicolet D; Kohlschmidt J; Papaioannou D; Genutis LK; Bill M; Powell BL; Uy GL; Kolitz JE; Carroll AJ; Stone RM; Garzon R; Byrd JC; Eisfeld AK; de la Chapelle A; Bloomfield CD
Blood Adv; 2021 Mar; 5(5):1474-1482. PubMed ID: 33683341
[TBL] [Abstract][Full Text] [Related]
20. Detection of CD34, TdT, CD56, CD2, CD4, and CD14 by flow cytometry is associated with NPM1 and FLT3 mutation status in cytogenetically normal acute myeloid leukemia.
Dalal BI; Mansoor S; Manna M; Pi S; Sauro GD; Hogge DE
Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):274-9. PubMed ID: 22481022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
